Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Compass Therapeutics (CMPX) Shares Outstanding (2022 - 2026)

Compass Therapeutics' Shares Outstanding history spans 5 years, with the latest figure at $180.1 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 30.23% to $180.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $180.1 million, a 30.23% increase, with the full-year FY2025 number at $178.3 million, up 29.39% from a year prior.
  • Shares Outstanding hit $180.1 million in Q1 2026 for Compass Therapeutics, up from $178.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding for CMPX hit a ceiling of $180.1 million in Q1 2026 and a floor of $126.3 million in Q4 2022.
  • Historically, Shares Outstanding has averaged $142.7 million across 5 years, with a median of $137.6 million in 2024.
  • Biggest five-year swings in Shares Outstanding: rose 0.5% in 2025 and later soared 30.23% in 2026.
  • Tracing CMPX's Shares Outstanding over 5 years: stood at $126.3 million in 2022, then increased by 1.08% to $127.7 million in 2023, then rose by 7.95% to $137.8 million in 2024, then grew by 29.39% to $178.3 million in 2025, then increased by 0.99% to $180.1 million in 2026.
  • Business Quant data shows Shares Outstanding for CMPX at $180.1 million in Q1 2026, $178.3 million in Q4 2025, and $177.6 million in Q3 2025.